BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
10/7/2014 5:32:00 PM | Browse: 917 | Download: 974
Publication Name World Journal of Gastroenterology
Manuscript ID 8438
Country/Territory South Korea
Received
2013-12-28 14:16
Peer-Review Started
2013-12-28 18:37
To Make the First Decision
2014-02-14 12:58
Return for Revision
2014-02-20 13:16
Revised
2014-03-10 11:04
Second Decision
2014-06-17 09:14
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief
2014-06-17 09:45
Articles in Press
2014-06-17 10:08
Publication Fee Transferred
Edit the Manuscript by Language Editor
2014-06-24 14:55
Typeset the Manuscript
2014-09-15 19:34
Publish the Manuscript Online
2014-10-07 17:32
ISSN 1007-9327 (print) and 2219-2840 (online)
Open Access
Copyright
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Gastroenterology and Hepatology
Manuscript Type Review
Article Title Predictive proteomic biomarkers for inflammatory bowel disease-associated cancer: Where are we now in the era of the next generation proteomics?
Manuscript Source Invited Manuscript
All Author List Jong-Min Park, Na Young Han, Young-Min Han, Mi Kyung Chung, Hoo Keun Lee, Kwang Hyun Ko, Eun-Hee Kim and Ki Baik Hahm
Funding Agency and Grant Number
Funding Agency Grant Number
Ministry of Education and Science Technology 2010-0002052
Korea and JSPS Asian CORE Program, Japan
Corresponding Author Ki Baik Hahm, MD, PhD, Professor, CHA Cancer Prevention Research Center, CHA University, 605 Yeoksam 1-dong, Gangnam-gu, Seoul 135-081, South Korea. hahmkb@cha.ac.kr
Key Words Inflammatory bowel disease; Biomarker; Proteomics; Tailored medicine; Colitic cancer
Core Tip Our recent achievements in discovering biomarkers to predict cancer risk are introduced. Ultimately, models based on combinations of genotype and gene expression data referenced with clinical, biochemical, and serological data may permit the development of tools for individualized risk stratification and efficient treatment selection, as well as complete rescue from complications, including colitis-associated cancer, in the near future.
Publish Date 2014-10-07 17:32
Citation Park JM, Han NY, Han YM, Chung MK, Lee HK, Ko KH, Kim EH, Hahm KB. Predictive proteomic biomarkers for inflammatory bowel disease-associated cancer: Where are we now in the era of the next generation proteomics? World J Gastroenterol 2014; 20(37): 13466-12476
URL http://www.wjgnet.com/1007-9327/full/v20/i37/13466.htm
DOI http://dx.doi.org/10.3748/wjg.v20.i37.13466
Full Article (PDF) WJG-20-13466.pdf
Full Article (Word) WJG-20-13466.doc
Manuscript File 8438-Review.docx
Answering Reviewers 8438-Answering reviewers.pdf
Copyright License Agreement 8438-Copyright assignment.PDF
Non-Native Speakers of English Editing Certificate 8438-Language certificate.pdf
Peer-review Report 8438-Peer reviews.pdf
Scientific Misconduct Check 8438-CrossCheck.jpg
Scientific Editor Work List 8438-Scientific editor work list.pdf